Ying Li

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

Jieqiong Liu, Qiang Liu, Ying Li et al. · Journal for ImmunoTherapy of Cancer · 2020 · 182 citations · Full text

Medicine, Oncology, Pharmacology +17

Ultrathin NiSe Nanosheets on Ni Foam for Efficient and Durable Hydrazine-Assisted Electrolytic Hydrogen Production

Ying Li, Yue Zhao, Fumin Li et al. · ACS Applied Materials & Interfaces · 2021 · 78 citations

Natural Sciences, Materials Engineering, Materials Science +17

Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis

Ying Li, Xin Zhao, Qiang Liu et al. · Annals of Medicine · 2021 · 57 citations · Full text

Medicine, Bioinformatics, Oncology +17

Efficient Copper‐Catalyzed Direct Amination of Aryl Halides Using Aqueous Ammonia in Water

Fei Meng, Xinhai Zhu, Ying Li et al. · European Journal of Organic Chemistry · 2010 · 46 citations

Natural Sciences, Chemistry, Catalysis +7

Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in advanced triple-negative breast cancer patients

Jieqiong Liu, Ying Li, Qian Li et al. · Breast Cancer Research and Treatment · 2021 · 35 citations

Medicine, Oncology, Pharmacology +14